Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sex Characteristics | 1 | 2018 | 311 | 0.500 |
Why?
|
| Health Behavior | 1 | 2018 | 385 | 0.460 |
Why?
|
| Cancer Survivors | 1 | 2018 | 258 | 0.440 |
Why?
|
| Feeding Behavior | 1 | 2018 | 706 | 0.380 |
Why?
|
| Anemia, Sickle Cell | 3 | 2020 | 325 | 0.350 |
Why?
|
| Bone Neoplasms | 3 | 2012 | 428 | 0.330 |
Why?
|
| Emergency Service, Hospital | 3 | 2024 | 1166 | 0.290 |
Why?
|
| Hydroxyurea | 2 | 2020 | 86 | 0.280 |
Why?
|
| Sarcoma, Ewing | 2 | 2012 | 111 | 0.260 |
Why?
|
| Menorrhagia | 1 | 2024 | 81 | 0.200 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 2012 | 9 | 0.190 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2024 | 138 | 0.180 |
Why?
|
| Mesenchymoma | 1 | 2011 | 2 | 0.180 |
Why?
|
| Humerus | 1 | 2011 | 14 | 0.180 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 230 | 0.160 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 639 | 0.160 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2019 | 110 | 0.150 |
Why?
|
| Adolescent | 11 | 2024 | 20002 | 0.140 |
Why?
|
| Drug Prescriptions | 1 | 2020 | 227 | 0.140 |
Why?
|
| Ovarian Neoplasms | 1 | 2012 | 443 | 0.140 |
Why?
|
| Algorithms | 1 | 2024 | 1633 | 0.130 |
Why?
|
| Graft vs Host Disease | 1 | 2012 | 631 | 0.130 |
Why?
|
| Patient Compliance | 1 | 2019 | 458 | 0.130 |
Why?
|
| Cerebrovascular Circulation | 1 | 2019 | 460 | 0.120 |
Why?
|
| Cardiomyopathies | 1 | 2011 | 500 | 0.120 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 452 | 0.110 |
Why?
|
| Genome, Human | 1 | 2011 | 1279 | 0.110 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 1728 | 0.100 |
Why?
|
| Mass Screening | 1 | 2019 | 802 | 0.100 |
Why?
|
| Yersinia | 1 | 2013 | 5 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 2304 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2012 | 97 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2012 | 75 | 0.090 |
Why?
|
| Child | 8 | 2020 | 25101 | 0.090 |
Why?
|
| DNA Mismatch Repair | 1 | 2011 | 45 | 0.090 |
Why?
|
| Stroke | 1 | 2019 | 1027 | 0.090 |
Why?
|
| Bone Diseases | 1 | 2011 | 42 | 0.090 |
Why?
|
| Histiocytosis, Sinus | 1 | 2011 | 32 | 0.090 |
Why?
|
| Child, Preschool | 4 | 2019 | 14347 | 0.090 |
Why?
|
| Hospitalization | 1 | 2020 | 1874 | 0.090 |
Why?
|
| Female | 12 | 2024 | 68330 | 0.080 |
Why?
|
| Cadherins | 1 | 2011 | 174 | 0.080 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 348 | 0.080 |
Why?
|
| Crohn Disease | 1 | 2013 | 290 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2020 | 1195 | 0.080 |
Why?
|
| Germ-Line Mutation | 1 | 2011 | 352 | 0.080 |
Why?
|
| Male | 8 | 2020 | 62543 | 0.060 |
Why?
|
| Fatal Outcome | 2 | 2012 | 358 | 0.060 |
Why?
|
| Humans | 13 | 2024 | 126753 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 622 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 973 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2012 | 1220 | 0.050 |
Why?
|
| Infant | 4 | 2020 | 12771 | 0.050 |
Why?
|
| Salpingectomy | 1 | 2012 | 15 | 0.050 |
Why?
|
| Ovariectomy | 1 | 2012 | 166 | 0.040 |
Why?
|
| Electron Transport Complex III | 1 | 2011 | 3 | 0.040 |
Why?
|
| Purkinje Fibers | 1 | 2011 | 7 | 0.040 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2012 | 85 | 0.040 |
Why?
|
| Orthopedic Procedures | 1 | 2012 | 75 | 0.040 |
Why?
|
| Disease Management | 1 | 2024 | 541 | 0.040 |
Why?
|
| District of Columbia | 1 | 2019 | 15 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2020 | 17005 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 5114 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2011 | 646 | 0.040 |
Why?
|
| Radiography | 1 | 2011 | 752 | 0.040 |
Why?
|
| Antisickling Agents | 1 | 2018 | 19 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2024 | 684 | 0.040 |
Why?
|
| RNA | 1 | 2011 | 518 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 1259 | 0.030 |
Why?
|
| Myocardium | 1 | 2011 | 847 | 0.030 |
Why?
|
| DNA | 1 | 2011 | 1419 | 0.030 |
Why?
|
| Prognosis | 1 | 2024 | 4772 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 1302 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 1753 | 0.030 |
Why?
|
| Registries | 1 | 2011 | 1536 | 0.030 |
Why?
|
| Yersinia pseudotuberculosis | 1 | 2013 | 5 | 0.030 |
Why?
|
| Yersinia enterocolitica | 1 | 2013 | 10 | 0.030 |
Why?
|
| Genes, Bacterial | 1 | 2013 | 215 | 0.020 |
Why?
|
| Abnormal Karyotype | 1 | 2012 | 8 | 0.020 |
Why?
|
| Incidence | 1 | 2019 | 3251 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2013 | 482 | 0.020 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2011 | 63 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2012 | 283 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2012 | 748 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 2507 | 0.020 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2012 | 219 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 898 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2012 | 3066 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2011 | 320 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 754 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2011 | 8347 | 0.020 |
Why?
|
| Young Adult | 2 | 2013 | 9665 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 1597 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 1284 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 912 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2012 | 12546 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 1861 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 3314 | 0.020 |
Why?
|
| United States | 1 | 2020 | 11310 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 1560 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 2039 | 0.010 |
Why?
|